Spectral Medical Inc T.EDT

Curious

[hmmmmmmmm]

If we are still blaming posters for weak and falling share prices?

Or are we starting to recognize that people don't like their money tied up in companies where management's main focus is on gross self enrichment- even when they fail at all of their stated goals..?

[mercedesman]

Can't speak for others, but I'm still blaming certain "Sh'ers" for failing to make an adequate distinction between LT underlying "value" and ST Share Price.   The classic problem is that somehow SP equates to intrinsic value in imperfect markets, especially w.r.t. Cdn incubator biotechs. I blame Mgt. for failing to "sell the story" in such a way

[oilandgasman]

A 20 year incubation period?... shillin like always.

[mercedesman]

Take a look at the average time to bring a drug/device to market in a US based, 28-day mortality RCT,  when there has been at least one "failed" attempt. Add in the complexity of solving Sepsis (versus other afflictions) and the only now emerging trend of personalized medicine, and companion diagnostics. Maybe you should stick to something like pot-stocks...especially since you

[oilandgasman]

"Take a look at the average time to bring a drug/device to market in a US based, 28-day mortality RCT,  when there has been at least one "failed" attempt". "analyzed 9,704 clinical development programs over the course of a decade from January 2011 to November 2020. They found that, on average, it took 10.5 years for a drug to get from Phase I to

[oilandgasman]

I'd add 5 years into the present trial and we've enrolled 60 something subjects. Puff puff pass shiller

[mercedesman]

Nice start on your homework, but you only completed 25% of your assignment D-  Now discuss: Time lost due to failed Phase 3 attempt in 2016  Added difficulties in cracking the Sepsis case ( with no new treatments worldwide in the past 30-40 years)  homogeneous populations in past RCTs (ie failures in patient selection/precision medicine) 2.5 years lost due to